Ami Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 12.35 Cr
as on 23-10-2024
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 735.44 Cr
as on 23-10-2024
- Satisfied Charges ₹ 570.53 Cr
as on 23-10-2024
- Revenue 12.20%
(FY 2023)
- Profit -63.13%
(FY 2023)
- Ebitda -24.02%
(FY 2023)
- Net Worth 2.98%
(FY 2023)
- Total Assets -0.46%
(FY 2023)
About Ami Lifesciences
The Corporate was formerly known as Sun Scope Laboratories Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.35 Cr.
The company currently has active open charges totaling ₹735.44 Cr. The company has closed loans amounting to ₹570.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ami Lifesciences Pvt Ltd India are Kirit Dharawat as CFO and Tarnnum Master as Company Secretary. Hirenkumar Shah, Virendrakumar Thakrar, Ameeshi Chovatia, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110GJ1994PTC021470
- Company No.
021470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 1994
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ami Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girishkumar Chovatia  | Managing Director | 24-Dec-2002 | Current |
| Kirit Dharawat | CFO | 01-Feb-2024 | Current |
| Tarnnum Master | Company Secretary | 21-Oct-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hirenkumar Shah | Whole-Time Director | 29-Dec-2023 | Current |
| Virendrakumar Thakrar | Whole-Time Director | 31-Jan-2024 | Current |
| Ameeshi Chovatia | Director | 21-Dec-2022 | Current |
| Kiranben Chovatia | Director | 31-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Ami Lifesciences.
Ami Lifesciences Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 12.2% increase. The company also saw a substantial fall in profitability, with a 63.13% decrease in profit. The company's net worth moved up by a moderate rise of 2.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ami Lifesciences?
In 2023, Ami Lifesciences had a promoter holding of 56.38% and a public holding of 43.62%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ami Drugs And Speciality Chemicals Private LimitedActive 21 years 10 monthsAmeeshi Chovatia, Girishkumar Chovatia and 1 more are mutual person
Ami Bio Tech Private LimitedActive 13 years 10 monthsAmeeshi Chovatia and Kiranben Chovatia are mutual person
Adc Finserv Private LimitedActive 4 years 4 monthsAmeeshi Chovatia and Kiranben Chovatia are mutual person
- Deltagene Biosciences Private LimitedActive 1 year 11 months
Girishkumar Chovatia and Kiranben Chovatia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 06 Sep 2024 | ₹25.00 Cr | Open |
Axis Bank Limited Creation Date: 28 Jun 2024 | ₹1.77 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 25 Sep 2023 | ₹35.00 Cr | Open |
How Many Employees Work at Ami Lifesciences?
Ami Lifesciences has a workforce of 1204 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ami Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ami Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
